Top blogs for pharma Secrets
January 21, 2025 In 21 CFR 211.94 it is mentioned that “Drug products containers and closures shall not be reactive, additive, or absorptive to alter the security, identification, toughness, quality or purity with the drug over and above the official or recognized prerequisites.” Even though the code will make this statement, and if expanded on